Skip to content

Susan Pekarovics, M.D.

NPI 1154350320ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Los Angeles, CA

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Los Angeles, California, licensed in CA, with an NPI issued in July 2006. In 2024 Medicare paid $841,054 for 196 patients, and Part D covered 4,561 of their prescriptions, 78% of them generic. Ibsa Pharma Inc. was the largest of 14 companies reporting payments in 2025, $1,175 in all, mostly food and beverage. Lists Cedars-Sinai Medical Center as a hospital affiliation.

Overview

NPI1154350320
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedJul 1, 2006
Last updated in NPPESMar 7, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (CA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients196
Services billed25,306 across 71 procedure codes
Paid by Medicare$841,054

Part D prescriptions in 2024

Prescriptions (claims)4,561 · 7,614 30-day fills
Patients166
Total drug cost$846,981
Generic share78% of claims

Medicare sources and data years

Education and affiliations

Graduation year1988
Medicare specialtyInternal Medicine
Secondary specialtiesEndocrinology
TelehealthOffers telehealth

Hospital affiliation

Other facilities

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$1,175 · 57 payments from 14 companies
  • 2024$1,144 · 51 payments from 15 companies

Top paying companies in 2025

CompanyAmountPayments
Ibsa Pharma Inc.$242.5013
Amgen Inc.$161.938
Astrazeneca Pharmaceuticals LP$148.907
Lilly USA, LLC$123.286
Novo Nordisk Inc$115.816

What the 2025 payments were for

  • Food and Beverage$1,175 · 57 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Los Angeles

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in California →